Description
SNAP-8 10mg is the Core Research catalogue item for 10mg nominal of SNAP-8, a commercial name used for acetyl octapeptide-3. It is supplied as one lyophilised research-peptide vial for in-vitro laboratory research only; not for human or veterinary use. The material and model-level science below must be distinguished from product-specific analytical results and finished-format performance.
What you receive and what needs verifying
| Field | What this product listing establishes |
|---|---|
| Exact catalogue item | SNAP-8 10mg |
| Labelled amount | 10mg nominal; not an independently measured quantitative assay |
| Presentation | one lyophilised research-peptide vial |
| Research identity | SNAP-8, a commercial name used for acetyl octapeptide-3 |
| Supply boundary | In-vitro laboratory research only; no personal or veterinary use |
| Current price and stock | Shown by the live WooCommerce purchase panel; not fixed in this description |
The vial is the catalogue item: no cartridge, dispensing pen, buffer or administration accessory is stated as part of this purchase. The labelled milligram value is an amount per vial, not a prepared-solution concentration.
Before ordering, check the material identity, the form on the actual label and any information your assay needs from the applicable certificate. An unrelated paper, a general PubChem record or another catalogue format cannot establish a batch value for this particular item.
Which compound or format is the right laboratory item?
Different from a neurotoxin or Argireline. SNAP-8 is not botulinum toxin, full-length SNAP-25 or acetyl hexapeptide-8 (Argireline). A study involving one is not proof of the same result for the others.
Related formats and research alternatives
SNAP-8, acetyl hexapeptide-8 and GHK-Cu are separate entities. Cosmetic & Skin Research catalogue includes compounds with different assay questions; the GHK-Cu 50mg vial is a copper peptide, not a SNAP-25-derived mimetic.
Scientific research: mechanisms, measured results and limits
The following is a selected, model-specific evidence summary, not a systematic review, treatment recommendation or release test of this product. Read the study species, methods and measured endpoints beside each finding before transferring an interpretation to a different assay.
SNAP-25 and vesicle-fusion biology
SNAP-25 is a cellular protein that participates with syntaxin and synaptobrevin/VAMP in the SNARE machinery coordinating regulated membrane fusion and exocytosis. The proteins form a complex that helps bring membranes together. This biology provides the context for studying short peptides derived from SNAP-25-like sequences, but SNAP-8 is not itself the full SNAP-25 protein and cannot be assumed to reproduce every interaction of a SNARE domain. 1
What the 2004 fragment experiments actually showed
Blanes-Mira and colleagues tested several peptides patterned after an N-terminal region of SNAP-25. In their assays, certain peptides disrupted SNARE-complex formation when present before assembly and altered calcium-dependent exocytosis in experimental cells. Their result concerned the specific sequences and conditions they used. It was not a trial of this supplier SNAP-8 material, a demonstration of topical skin penetration, or proof of a clinical muscle-relaxation effect. The timing of peptide exposure in the experiment is an important limiting condition. 2
SNAP-8 and acetyl hexapeptide-8 are not the same name
SNAP-8 is commonly used for acetyl octapeptide-3, an eight-residue cosmetic-research peptide. Acetyl hexapeptide-8, often marketed as Argireline, is a different six-residue peptide. Results for an Argireline experiment or for an N-terminal SNAP-25 fragment cannot be assigned to SNAP-8 without testing the exact chemical species. Terminal acetylation, amidation and residue order may change both mass and behaviour, so they also belong in the actual product specification.
Direct evidence for the named octapeptide is limited
The established SNARE mechanism is a real cellular system; that alone does not establish an independently controlled clinical effect for acetyl octapeptide-3. Manufacturer ingredient data, comparisons among marketed peptide mixtures and cell-based work on related peptide fragments are different evidence types. This product page deliberately does not quote a wrinkle-depth reduction or a superiority percentage as a demonstrated result for SNAP-8. A defensible laboratory hypothesis begins with verified identity and an assay that measures the relevant molecular event rather than a cosmetic outcome claim. 1,2
How to interpret the evidence for this product
| Research context | Reported or relevant endpoint | Interpretation limit |
|---|---|---|
| SNARE-complex biochemical studies | Assembly and membrane-fusion machinery | Explains the protein target, not SNAP-8 efficacy |
| SNAP-25-derived peptide experiments | Complex formation and cell exocytosis | Different tested peptide sequences and assay conditions |
| Named acetyl octapeptide-3 product | Actual identity, terminal chemistry and lot data | Not established by another peptide paper |
Batch documentation before purchase
Core Research allows a pre-purchase batch-documentation enquiry. Use Batch Documentation or email info@core-research.net with the exact product name and presentation. An order or container lot number is not needed to ask the question before purchase; to match a supplied item after delivery, retain its lot identifier and order reference. The published delivery policy says a certificate is issued with a consignment where one exists for the supplied lot; that is not a promise of a current certificate for every item.
Ask whether documentation applies to the lot proposed for supply and identifies the tested chemical form, sample description, method, result, reporting basis, testing issuer and relevant dates. The difference between chromatographic peak-area purity, identity/mass and quantitative vial content matters.
For interpretation, use guide to reading a CoA, HPLC testing guide and mass-spectrometry guide. A theoretical molecular formula is not a batch-assay result, and a product label does not certify sterility.
For SNAP-8 10mg, confirm the octapeptide sequence, acetylation and other terminal modifications rather than substituting the mass of a six-residue Argireline compound. Reports about related peptides are not direct quality-control measurements of this material.
Storage, receiving and laboratory quality control
A lyophilised vial is different from a liquid solution. Check the lot-specific storage document rather than importing a generic reconstitution or stability period.
Follow the supplied label and product-specific documentation for storage conditions, temperature excursions and expiry. The time limits for dry peptide, a mixed solution, or a liquid-filled cartridge can differ. No generic fixed storage term, purity threshold or cold-chain guarantee is inserted here without applicable evidence. See peptide storage guidance and research-product receiving checklist for general laboratory-record practices.
At receipt, compare the product name, labelled amount and presentation with your order. Inspect the vial closure or cartridge/packaging, record the lot identifier and retain the accompanying paperwork. If damaged, delayed or different from the order, record photographs and contact Core Research before using the material. This records receipt conditions; it does not substitute for an identity assay.
Ordering questions
Does the labelled milligram amount state purity or a prepared concentration?
No. 10mg is the catalogue-labelled quantity for this item. It does not by itself establish analytical content, purity, final liquid concentration, sample mass basis or number of experiments. The applicable material documentation and your laboratory’s own method establish those details.
Where is the product dispatched from and what is the delivery policy?
Core Research states that it dispatches from Birmingham, United Kingdom, using plain external packaging. Delivery service, charge and arrival estimates depend on the destination and order; see Shipping & Delivery. Tracking is provided in dispatch communications where available. There is no universal next-day delivery or free-shipping promise on this page.
Can I obtain an applicable certificate before ordering?
You can request information before ordering through Batch Documentation. Specify SNAP-8 10mg, the vial presentation and any required test/method. Whether a particular current lot has a document, and what it actually reports, must be checked rather than assumed.
Can an institution request a quotation?
Yes. Institutional Procurement describes the written quotation and purchase-order-reference enquiry route. Include the institution, delivery details, exact product and quantity, and any lot or technical requirements. An enquiry does not itself reserve stock or guarantee credit terms.
Is this product suitable for human or veterinary use?
No. This listing is for in-vitro laboratory research only. Neither a positive model result nor a named medicinal compound establishes human-use suitability, and this page gives no preparation, dosing or administration instructions. See Research Use Only policy.
Order or enquire about SNAP-8 10mg
Use the native product purchase panel to select the listed quantity and the checkout options available for your order. For identity, format, lot-documentation or delivery questions, contact Core Research before purchase. Current price and stock remain controlled by WooCommerce, not hard-coded in this description.
Selected research references
[1] Roth & Burgoyne (1994). SNAP-25 participation in a membrane-fusion SNARE complex. PMID 8082766. Primary research record.
[2] Blanes-Mira C et al. (2004). Peptides patterned after the SNAP-25 N-terminus inhibit SNARE assembly and regulated exocytosis. Journal of Neurochemistry. PMID 14675156. DOI 10.1046/j.1471-4159.2003.02133.x. Primary research record.


